When compared to MEDI9447, IPH5301 managed to block AMP hydrolysis at the membrane of cancer cells and also the activity of soluble CD73 at least as effectively as MEDI9447, but, unlike the latter, it did not downregulate the expression of CD73 on membranes of cancer cells, implying a different mechanism of action. The gene discussed is NT5E; the disease is cancer.